Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2004
07/22/2004WO2004060378A2 Compositions comprising particles containing alumina with compounds bound to the alumina surface, delivery systems and methods of preparation thereof
07/22/2004WO2004060377A1 Derivatives of prostaglandins for treating abdominal discomfort
07/22/2004WO2004060375A1 A method for treating renal failure
07/22/2004WO2004060374A1 Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
07/22/2004WO2004060373A1 Therapeutic agent for wet age-related macular degeneration
07/22/2004WO2004060372A1 Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer
07/22/2004WO2004060370A1 Treatment of hiv infection through combined administration of tipranavir and capravirine
07/22/2004WO2004060369A1 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes
07/22/2004WO2004060368A1 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes by increasing the number of islets of langerhans cells
07/22/2004WO2004060367A1 Imidazole and triazole derivatives useful as selective cox-1 inhibitors
07/22/2004WO2004060366A1 A method for the treatment, prevention, or inhibition of a cns disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof
07/22/2004WO2004060365A1 Compositions and methods for treating lung cancer
07/22/2004WO2004060364A1 Skin lightening composition
07/22/2004WO2004060362A2 COMPOSITIONS AND METHODS FOR INHIBITING TGF-β
07/22/2004WO2004060361A2 Combination of reboxetine and a cyclooxygenase-2 inhibitor
07/22/2004WO2004060360A1 Use of active ingredients for the prophylaxis and/or therapy of viral diseases
07/22/2004WO2004060357A1 Acid labile drug compositions
07/22/2004WO2004060355A1 Multilayer Dosage Forms Containing NSAIDs and Triptans
07/22/2004WO2004060353A1 Solid dispersions comprising a hygroscopic and/or deliquescent drug
07/22/2004WO2004060352A1 Non-hygroscopic formulation comprising a hydroscopic drug
07/22/2004WO2004060351A2 Pharmaceutical formulation with an insoluble active agent for pulmonary administration
07/22/2004WO2004060348A2 Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium
07/22/2004WO2004060345A2 Dispersible pharmaceutical compositions
07/22/2004WO2004060341A2 Increasing skin cell renewal with water-soluble vitamin e
07/22/2004WO2004060322A2 Pharmaceutical preparations for treatments of diseases and disorders of the breast
07/22/2004WO2004060321A2 Cardioprotective delta opioid receptor agonists and methods of using same
07/22/2004WO2004060320A2 Methods of improving health-related quality of life in individuals with systemic lupus erythematosus
07/22/2004WO2004060319A2 Immunostimulatory combinations
07/22/2004WO2004060318A2 Drug-coated stents and methods of use therefor
07/22/2004WO2004060314A2 Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
07/22/2004WO2004060313A2 Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses
07/22/2004WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators
07/22/2004WO2004060306A2 Anti-inflammatory medicaments
07/22/2004WO2004060305A2 Anti-cancer medicaments
07/22/2004WO2004060303A2 Methods and reagents for the enhancement of virus transduction in the bladder epithelium
07/22/2004WO2004060302A2 Methods and compositions for the diagnosis, prognosis, and treatment of cancer
07/22/2004WO2004060288A2 Topical compositions having a natural ingredient and method of use
07/22/2004WO2004060287A2 Use of 2-nitropropanol, 2-nitroethane, and 2-nitroethanol for control of microbial pathogens
07/22/2004WO2004060286A2 Methods for the treatment of pain and traumatic injury using benzamides and compositions containing the same
07/22/2004WO2004060283A2 Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
07/22/2004WO2004060279A2 Use of silver sulfadiazine for viral aliments, and preparations and combinations therefor
07/22/2004WO2004060263A2 Magnesium salt of imidazole derivative
07/22/2004WO2004060261A2 Novel factor viia inhibiting compounds
07/22/2004WO2004060212A1 Anti-inflammatory coating for implantable medical devices
07/22/2004WO2004060146A2 Method of treatment for central nervous system injury
07/22/2004WO2004050115A3 Combination treatment using exendin-4 and thiazolidinediones
07/22/2004WO2004045591A3 Liquid pharmaceutical formulations containing 3,7-diazabicyclo`3,3,1! nonanes for treating anti-arrhythmic events
07/22/2004WO2004043456A8 Cholesterol absorption inhibitors for the treatment of demyelination
07/22/2004WO2004043339A3 Substituted cycloalkyl p1' hepatitis c virus inhibitors
07/22/2004WO2004041324A3 Transdermal delivery of fentanyl
07/22/2004WO2004041291A9 High affinity receptors for helicobacter pylori and use thereof
07/22/2004WO2004041269A3 New use for pharmaceutical composition
07/22/2004WO2004041118A3 Therapeutic compositions for drug delivery to and through covering epithelia
07/22/2004WO2004039817A9 Cardiolipin molecules and method of synthesis
07/22/2004WO2004039359A3 Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders
07/22/2004WO2004039330A3 Compounds, methods and devices for inhibiting neoproliferative changes in blood vessel walls
07/22/2004WO2004039313A3 Preventing desensitization of receptors
07/22/2004WO2004037773A8 Phenethanolamine derivative for the treatment of respiratory diseases
07/22/2004WO2004037235A3 Method and composition for preventing and treating solid tumors
07/22/2004WO2004037203A9 Sustained release l-arginine formulations and methods of manufacture and use
07/22/2004WO2004037187A8 Metal-containing materials, compositions and methods
07/22/2004WO2004037186A8 Prophylactic treatment methods
07/22/2004WO2004035034A3 Clofarabine and taxane chemotherapy combination
07/22/2004WO2004035033A3 Clofarabine and camptothecin chemotherapy combination
07/22/2004WO2004034983A3 Preparation of triazospiro compounds
07/22/2004WO2004034963A3 Methods and compositions using cholinesterase inhibitors
07/22/2004WO2004033417A3 S-adenosyl methionine decarboxylase inhibition for the treatment of a herpes simplex virus infection
07/22/2004WO2004027049B1 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells
07/22/2004WO2004026253A3 Novel lapacho compounds and methods of use thereof
07/22/2004WO2004026225A3 Therapeutic agents and corresponding treatments
07/22/2004WO2004024126B1 Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin
07/22/2004WO2004024086A3 Compounds, compositions and methods
07/22/2004WO2004012674A3 Development of muscle mass in a mammal
07/22/2004WO2004006843A3 Combination therapies with l-fmau for the treatment of hepatitis b virus infection
07/22/2004WO2004006835A3 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
07/22/2004WO2004002406A3 Bicyclic pyrimidinones as coagulation cascade inhibitors
07/22/2004WO2003103583A8 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system
07/22/2004WO2003094965A3 Modulation of neural stem cells with s1p or lpa receptor agonists
07/22/2004WO2003088901A3 Oral rehydration composition
07/22/2004WO2003087304A3 Tri-substituted heteroaryls and methods of making and using the same
07/22/2004WO2003087086A3 Substituted indoles
07/22/2004WO2003077863A3 Method for overexpression of zwitterionic polysaccharides
07/22/2004WO2003072757A3 Nucleotide mimics and their prodrugs
07/22/2004WO2003072135A3 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
07/22/2004WO2003070675A3 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors
07/22/2004WO2003059293A3 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators
07/22/2004WO2003051398A8 Parenteral composition of paracetamol
07/22/2004WO2003044014A8 Indole-2-carboxamides as factor xa inhibitors
07/22/2004WO2003039477A3 Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding
07/22/2004WO2003017919A3 Composition comprising wenguanguo extracts, methods for preparing same and uses therof
07/22/2004WO2003014299A3 SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
07/22/2004WO2003014296A3 A group of novel anti-cancer compounds with specific structure
07/22/2004WO2003006002A9 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases
07/22/2004WO2002102232A3 A novel signaling pathway for the production of inflammatory pain and neuropathy
07/22/2004WO2002101076A3 Methods for targeted expression of therapeutic nucleic acid
07/22/2004WO2002099048A3 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
07/22/2004WO2002096886A8 Pyrimidine derivatives
07/22/2004WO2002088090A3 Pyrazole derived kinase inhibitors
07/22/2004WO2002078637A3 Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla)
07/22/2004US20040143136 hydrolysis of 4,4-dimethyl-2-oxetanone with aqueous sodium hydroxide; absorbion onto synthetic silicic acid; lightly hygroscopic and easily handled.